UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Trials and Good Clinical Practice

Journal of health science (Tokyo, Japan), 2010, Vol.56 (3), p.231-238

Suzuki-Nishimura, Tamiko

2010

Volltextzugriff (PDF)

S1E-7-4 Challenges to innovative drug discovery by academia in Japan: Strategies to solve difficulties

Journal of Pharmacological Sciences, 2014-02, Vol.124 (suppl), p.30-30

Tamiko Suzuki-Nishimura

2014

Volltextzugriff (PDF)

Identification of NDRG1 as an early inducible gene during in vitro maturation of cultured mast cells

Biochemical and biophysical research communications, 2003-06, Vol.306 (2), p.339-346

2003

Volltextzugriff (PDF)

P2J-22-4 Safety of recently approved monoclonal and polyclonal antibodies for human use

Journal of Pharmacological Sciences, 2010, Vol.112 (suppl), p.216-216

Tamiko Suzuki-Nishimura

2010

Volltextzugriff (PDF)

Case of a neutrophilic dermatosis involving lung abscess after influenza vaccination

Journal of dermatology, 2017-03, Vol.44 (3), p.e11-e12

2017

Volltextzugriff (PDF)

P2-96 Inhibitory effects of GlcNAc polymers on the histamine release from mast cells by Datura stramonium agglutinin

Journal of Pharmacological Sciences, 2013-03, Vol.121 (suppl), p.196-196

2013

Volltextzugriff (PDF)

P3M-A12-6 Importance of the pharmaco-dynamics of monoclonal antibodies for human use during risk evaluation in the review process

Journal of Pharmacological Sciences, 2009, Vol.109 (suppl.2), p.270-270

Tamiko Suzuki-Nishimura

2009

Volltextzugriff (PDF)

P1J-07 Non-clinical safety of monoclonal antibodies for human use

Journal of Pharmacological Sciences, 2008, Vol.106 (suppl.2), p.148-148

Tamiko Suzuki-Nishimura

2008

Volltextzugriff (PDF)

P1-150 Non-clinical safety of recently approved monoclonal antibodies for human use

Journal of Pharmacological Sciences, 2007, Vol.103 (suppl.2), p.161-161

Tamiko Suzuki-Nishimura

2007

Volltextzugriff (PDF)

P3J18-2 Non-clinical studies of recently approved monoclonal antibodies for human use and ICH guidelines

Journal of Pharmacological Sciences, 2011, Vol.115 (suppl.2), p.275-275

2011

Volltextzugriff (PDF)

P3N-12 Non-clinical safety and human subject protection during clinical trials of monoclonal antibodies and their analogs for human use

Journal of Pharmacological Sciences, 2006, Vol.100 (suppl.2), p.285-285

Tamiko Suzuki-Nishimura

2006

Volltextzugriff (PDF)

P2-19-1 Nonclinical studies of monoclonal antibodies for human use approved in 2011

Journal of Pharmacological Sciences, 2012, Vol.118 (suppl), p.216-216

2012

Volltextzugriff (PDF)

GLP (Good Laboratory Practice) for new drug application in Japan

Journal of Pharmacological Sciences, 2005, Vol.97 (suppl.2), p.233-233

Tamiko Suzuki-Nishimura

2005

Volltextzugriff (PDF)

Scientific Drug Safety Information for Patients' Consent

YAKUGAKU ZASSHI, 2011/06/01, Vol.131(6), pp.871-875

SUZUKI-NISHIMURA, Tamiko

2011

Volltextzugriff (PDF)

Patients' Consent and Drug Safety of Investigational Products and Approved Drugs

Yakugaku zasshi, 2011-06, Vol.131 (6), p.863-863

2011

Volltextzugriff (PDF)

Patients' Consent and Drug Safety of Investigational Products and Approved Drugs

YAKUGAKU ZASSHI, 2011/06/01, Vol.131(6), pp.863-863

2011

Volltextzugriff (PDF)

Clinical development of new drugs and pharmacology

Folia Pharmacologica Japonica, 2011, Vol.138(5), pp.201-204

Suzuki-Nishimura, Tamiko

2011

Volltextzugriff (PDF)

Induction of PYPAF1 during In Vitro Maturation of Mouse Mast Cells

Journal of biochemistry (Tokyo), 2003-11, Vol.134 (5), p.699-709

2003

Volltextzugriff (PDF)

Lithium carbonate inhibited the histamine release induced by bradykinin, substance P, compound 48/80 and GlcNAc-specific lectin Datura stramonium agglutinin

Proceedings for Annual Meeting of The Japanese Pharmacological Society, 2018, Vol.WCP2018, p.PO3-4-11

2018

Volltextzugriff (PDF)

Non-clinical safety of new biological drugs for rheumatoid arthritis treatment

Journal of Pharmacological Sciences, 2004, Vol.94 (suppl.2), p.201-201

2004

Volltextzugriff (PDF)

Face-to-face consultation meetings on new biotechnological/biological products in JAPAN

Journal of Pharmacological Sciences, 2003, Vol.91 (suppl.2), p.285-285

2003

Volltextzugriff (PDF)

Inhibition by calcium antagonists of histamine release and calcium influx of rat mast cells: Difference between induction of histamine release by concanavalin A and compound 48/80

European journal of pharmacology, 1982-01, Vol.85 (2), p.155-161

1982

Volltextzugriff (PDF)

GLP inspection for global drug development

Folia Pharmacologica Japonica, 2007, Vol.130(5), pp.408-411

Suzuki-Nishimura, Tamiko

2007

Volltextzugriff (PDF)

Haptenic activity of galactosyl ceramide and its topographical distribution on liposomal membranes I. effect of cholesterol incorporation

Biochimica et biophysica acta. Biomembranes, 1981-06, Vol.644 (2), p.183-191

1981

Volltextzugriff (PDF)

D-Galactose-Specific Sea Urchin Lectin Sugar-Specifically Inhibited Histamine Release Induced by Datura stramonium Agglutinin: Differences Between Sugar-Specific Effects of Sea Urchin Lectin and Those of D-Galactose- or L-Fucose-Specific Plant Lectins

The Japanese Journal of Pharmacology, 2001, Vol.85(4), pp.443-452

2001

Volltextzugriff (PDF)

1 – 25 von 239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(211)

Publikationsform

Sprache

Englisch
(180)
Japanisch
(66)

Erscheinungsjahr

n.n

Thema

Science & Technology
(88)
Life Sciences & Biomedicine
(81)
Humans
(59)
Male
(51)
Animals
(38)
Biological And Medical Sciences
(34)
Female
(34)
Rats
(28)
Pharmacology & Pharmacy
(25)
Medical Sciences
(23)
Mast Cells - Drug Effects
(21)
Mast Cells - Metabolism
(21)
Middle Aged
(20)
Histamine Release - Drug Effects
(17)
Aged
(15)
Mast Cell
(15)
Fundamental And Applied Biological Sciences. Psychology
(14)
Adult
(13)
In Vitro Techniques
(13)
Rats, Inbred Strains
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical Trials and Good Clinical Practice

S1E-7-4 Challenges to innovative drug discovery by academia in Japan: Strategies to solve difficulties

Identification of NDRG1 as an early inducible gene during in vitro maturation of cultured mast cells

P2J-22-4 Safety of recently approved monoclonal and polyclonal antibodies for human use

Case of a neutrophilic dermatosis involving lung abscess after influenza vaccination

P2-96 Inhibitory effects of GlcNAc polymers on the histamine release from mast cells by Datura stramonium agglutinin

P3M-A12-6 Importance of the pharmaco-dynamics of monoclonal antibodies for human use during risk evaluation in the review process

P1J-07 Non-clinical safety of monoclonal antibodies for human use

P1-150 Non-clinical safety of recently approved monoclonal antibodies for human use

P3J18-2 Non-clinical studies of recently approved monoclonal antibodies for human use and ICH guidelines

P3N-12 Non-clinical safety and human subject protection during clinical trials of monoclonal antibodies and their analogs for human use

P2-19-1 Nonclinical studies of monoclonal antibodies for human use approved in 2011

GLP (Good Laboratory Practice) for new drug application in Japan

Scientific Drug Safety Information for Patients' Consent

Patients' Consent and Drug Safety of Investigational Products and Approved Drugs

Patients' Consent and Drug Safety of Investigational Products and Approved Drugs

Clinical development of new drugs and pharmacology

Induction of PYPAF1 during In Vitro Maturation of Mouse Mast Cells

Lithium carbonate inhibited the histamine release induced by bradykinin, substance P, compound 48/80 and GlcNAc-specific lectin Datura stramonium agglutinin

Non-clinical safety of new biological drugs for rheumatoid arthritis treatment

Face-to-face consultation meetings on new biotechnological/biological products in JAPAN

Inhibition by calcium antagonists of histamine release and calcium influx of rat mast cells: Difference between induction of histamine release by concanavalin A and compound 48/80

GLP inspection for global drug development

Haptenic activity of galactosyl ceramide and its topographical distribution on liposomal membranes I. effect of cholesterol incorporation

D-Galactose-Specific Sea Urchin Lectin Sugar-Specifically Inhibited Histamine Release Induced by Datura stramonium Agglutinin: Differences Between Sugar-Specific Effects of Sea Urchin Lectin and Those of D-Galactose- or L-Fucose-Specific Plant Lectins

Suchergebnisse filtern